Talidomida (Catalan Wikipedia)

Silverman, William «The Schizophrenic Career of a "Monster Drug"». Pediatrics, 110, 2, 22-04-2002, p. 404–6. Arxivat de l'original el 2007-02-02. DOI: 10.1542/peds.110.2.404. PMID: 12165600 [Consulta: 15 novembre 2011].

acs.org (Global: 865^th place; Catalan: 519^th place)

pubs.acs.org

Rouhi, Maureen. «Thalidomide». Chemical & Engineering News. Societat Química Americana. [Consulta: 21 setembre 2006].

archive.org (Global: 6^th place; Catalan: 15^th place)

Heaton, C. A.. The Chemical Industry. Springer, 1994, p. 40. ISBN 0751400181.
Eccles H; Ratcliff B. Chemistry 2. Cambridge University Press, 2001, p. 170. ISBN 978-0-521-79882-2.

archive.today (Global: 28^th place; Catalan: 10^th place)

Foggo, Daniel «Thalidomide 'was created by the Nazis'». The Times [Londres], 08-02-2009 [Consulta: 18 juny 2009]. Arxivat 2011-06-29 at Archive.is

bbc.co.uk (Global: 11^th place; Catalan: 21^st place)

news.bbc.co.uk

Anon «Thalidomide:40 years on». BBC news. BBC, 07-06-2002 [Consulta: 1r maig 2009].
«Apology for thalidomide survivors». BBC News:Health. BBC News, 14 gener 2010 [Consulta: 14 gener 2010].
Ryan, Caroline «They just didn't know what it would do». BBC News:Health. BBC news, 1 abril 2004 [Consulta: 1r maig 2009].
«Compensation offer on Thalidomide». BBC News, 7 juliol 2005 [Consulta: 26 juliol 2011].
«Thalidomide survivors to get £20m». BBC News, 23 desembre 2009 [Consulta: 26 juliol 2011].

bbc.co.uk

Anon. «Thalidomide — A Second Chance? — programme summary». BBC. [Consulta: 1r maig 2009].

benthamdirect.org (Global: low place; Catalan: low place)

Raghupathy R, Billett HH «Promising therapies in sickle cell disease». Cardiovasc Hematol Disord Drug Targets, 9, 1, març 2009, p. 1–8. Arxivat de l'original el 2013-05-11. DOI: 10.2174/187152909787581354. PMID: 19275572 [Consulta: 27 juny 2021]. Arxivat 2013-05-11 a Wayback Machine.

bhj.org (Global: low place; Catalan: low place)

Moghe, Vijay V; Ujjwala Kulkarni, Urvashi I Parmar «Thalidomide» (PDF). Bombay Hospital Journal. Bombay Hospital [Bombai], 50, 3, 2008, p. 446. Arxivat de l'original el 22 de juliol 2011 [Consulta: 25 octubre 2009]. Arxivat 22 de juliol 2011 a Wayback Machine.

biopoliticaltimes.org (Global: low place; Catalan: low place)

Washington, Harriet A.. «Prudence and the Pill: Testing Thalidomide in the Global South», 14 gener 2011. Arxivat de l'original el 5 de novembre 2011. [Consulta: 15 novembre 2011].

birthdefects.org (Global: low place; Catalan: low place)

Mekdeci, Betty. «How a Commonly Used Drug Caused Birth Defects». Arxivat de l'original el 2013-12-18. [Consulta: 15 novembre 2011].
Mekdeci, Betty. «How a Commonly Used Drug Caused Birth Defects». Arxivat de l'original el 2013-12-18. [Consulta: 15 novembre 2011].

bris.ac.uk (Global: 5,759^th place; Catalan: 2,885^th place)

chm.bris.ac.uk

Ligham, Alex. «Optical Isomerism In Thalidomide». Thalidomide, abril 2000. [Consulta: 2 maig 2009].

cancerbackup.org.uk (Global: low place; Catalan: low place)

Anon. «Thalidomide». Cancer treatments. Cancerbackup. [Consulta: 1r maig 2009].

channel4.com (Global: 1,192^nd place; Catalan: 1,558^th place)

Anon. «Born Freak». Happy Birthday Thalidomide. Channel 4. [Consulta: 1r maig 2009].

clinicaltrials.gov (Global: 4,259^th place; Catalan: 3,031^st place)

Search of: pomalidomide — ClinicalTrials.gov

dailymail.co.uk (Global: 338^th place; Catalan: 277^th place)

Courtenay-Smith «A truly special love story: Two married thalidomide survivors living happily 50 years after drug's launch». The Daily Mail [Londres], 23-04-2008 [Consulta: 18 juny 2009].

doi.org (Global: 2^nd place; Catalan: 4^th place)

dx.doi.org

Ito, T; Ando, H; Suzuki, T [et al]. «Identification of a primary target of thalidomide teratogenicity». Science, 327, 5971, març 2010, p. 1345–50. DOI: 10.1126/science.1177319. PMID: 20223979.
Silverman, William «The Schizophrenic Career of a "Monster Drug"». Pediatrics, 110, 2, 22-04-2002, p. 404–6. Arxivat de l'original el 2007-02-02. DOI: 10.1542/peds.110.2.404. PMID: 12165600 [Consulta: 15 novembre 2011].
Rao KV «Lenalidomide in the treatment of multiple myeloma». American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists, 64, 17, September 2007, p. 1799–807. DOI: 10.2146/ajhp070029. PMID: 17724360 [Consulta: 18 juny 2009].
Castilla, E.E. [et al]. «Thalidomide, a current teratogen in South America». Teratology. Wiley-Liss, 54, 6, 1996, p. 273–7. Arxivat de l'original el 2012-03-24. DOI: 10.1002/(SICI)1096-9926(199612)54:6<273::AID-TERA1>3.0.CO;2-#. PMID: 9098920 [Consulta: 15 novembre 2011]. Arxivat 2012-03-24 a Wayback Machine.
Paumgartten, J.R.; Chahoud, Ibrahim «Thalidomide embryopathy cases in Brazil after 1965». Reproductive Toxicology, 22, 1, 2006, p. 1-2. DOI: 10.1016/j.reprotox.2005.11.007.
Madnani NA, Khan KJ «Linear IgA bullous dermatosis of childhood: Response to thalidomide». Indian Journal of Dermatology, Venereology, and Leprology, 76, 4, 2010, p. 427. DOI: 10.4103/0378-6323.66601. PMID: 20657136.^{[Enllaç no actiu]}
Brown, RD; Spencer A, Ho PJ, Kennedy N, Kabani K, Yang S, Sze DM, Aklilu E, Gibson J, Joshua DE «Prognostically significant cytotoxic T cell clones are stimulated after thalidomide therapy in patients with multiple myeloma». Leukemia & Lymphoma, 50, 11, 2009 Nov, p. 1860–4. DOI: 10.3109/10428190903216804. PMID: 19883313 [Consulta: 4 juny 2011].
Ghassem, Solgi; Kariminia A., Abdi K, Darabi M, Ghareghozloo B. «Effects of combined therapy with thalidomide and glucantime on leishmaniasis induced by Leishmania major in BALB/c mice» (PDF). Korean Journal of Parasitology, 44, 1, març 2006, p. 55–61. Arxivat de l'original el 2012-05-03. DOI: 10.3347/kjp.2006.44.1.55. PMC: 2532651. PMID: 16514283 [Consulta: 15 novembre 2011]. Arxivat 2012-05-03 a Wayback Machine.
Lebrin, Franck; Srun S., Raymond2 K, Martin S., van den Brink S, Freitas C., Bréant C., Mathivet T., Larrivée B., Thomas J., Arthur H., Westermann C., Disch F., Mager J., Snijder R., Eichmann A., Mummery C. «Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia». Nature Medicine, 16, 4, abril 2010, p. 420–8. DOI: 10.1038/nm.2131. PMID: 20364125.
Singhal S, Mehta J, Desikan R, et al. «Antitumor activity of thalidomide in refractory multiple myeloma». The New England Journal of Medicine, 341, 21, November 1999, p. 1565–71. DOI: 10.1056/NEJM199911183412102. PMID: 10564685 [Consulta: 18 juny 2009].
Gieseler F «Pathophysiological considerations to thrombophilia in the treatment of multiple myeloma with thalidomide and derivates». Thrombosis and Haemostasis, 99, 6, June 2008, p. 1001–7. DOI: 10.1160/TH08-01-0009. PMID: 18521500 [Consulta: 18 juny 2009].
Denz U, Haas PS, Wäsch R, Einsele H, Engelhardt M «State of the art therapy in multiple myeloma and future perspectives». European Journal of Cancer (Oxford, England : 1990), 42, 11, July 2006, p. 1591–600. DOI: 10.1016/j.ejca.2005.11.040. PMID: 16815703 [Consulta: 18 juny 2009].
Haas PS, Denz U, Ihorst G, Engelhardt M «Thalidomide in consecutive multiple myeloma patients: single-center analysis on practical aspects, efficacy, side effects and prognostic factors with lower thalidomide doses». Eur. J. Haematol., 80, 4, abril 2008, p. 303–9. DOI: 10.1111/j.1600-0609.2007.01022.x. PMID: 18182082.
Bennett CL, Angelotta C, Yarnold PR, et al. «Thalidomide- and lenalidomide-associated thromboembolism among patients with cancer». JAMA, 296, 21, December 2006, p. 2558–60. DOI: 10.1001/jama.296.21.2558-c. PMID: 17148721.
Teo SK, Colburn WA, Tracewell WG, Kook KA, Stirling DI, Jaworsky MS, Scheffler MA, Thomas SD, Laskin OL «Clinical pharmacokinetics of thalidomide». Clin Pharmacokinet., 43, 5, 2004, p. 311–327. DOI: 10.2165/00003088-200443050-00004. PMID: 15080764.
Stephens TD, Bunde CJ, Fillmore BJ «Mechanism of action in thalidomide teratogenesis». Biochemical Pharmacology, 59, 12, June 2000, p. 1489–99. DOI: 10.1016/S0006-2952(99)00388-3. PMID: 10799645.
Huang PH, McBride WG «Interaction of [glutarimide-2-14C]-thalidomide with rat embryonic DNA in vivo». Teratogenesis, Carcinogenesis, and Mutagenesis, 17, 1, 1997, p. 1–5. DOI: 10.1002/(SICI)1520-6866(1997)17:1<1::AID-TCM2>3.0.CO;2-L. PMID: 9249925.
Therapontos C, Erskine L, Gardner ER, Figg WD, Vargesson N «Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation». Proceedings of the National Academy of Sciences of the United States of America, 106, 21, May 2009, p. 8573–8. DOI: 10.1073/pnas.0901505106. PMC: 2688998. PMID: 19433787 [Consulta: 18 juny 2009].
Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H «Identification of a primary target of thalidomide teratogenicity». Science, 327, 5971, 2010, p. 1345–1350. DOI: 10.1126/science.1177319. PMID: 20223979.
Anderson, KC «Lenalidomide and thalidomide: mechanisms of action--similarities and differences». Semin Hematol., Vol. 42, num. 4 Suppl 4, 2005, p. S3-8. DOI: http://dx.doi.org/10.1053/j.seminhematol.2005.10.001. PMID: 16344099.
Raghupathy R, Billett HH «Promising therapies in sickle cell disease». Cardiovasc Hematol Disord Drug Targets, 9, 1, març 2009, p. 1–8. Arxivat de l'original el 2013-05-11. DOI: 10.2174/187152909787581354. PMID: 19275572 [Consulta: 27 juny 2021]. Arxivat 2013-05-11 a Wayback Machine.

drugsafetysite.com (Global: low place; Catalan: low place)

«Thalidomide: Drug safety during pregnancy and breastfeeding / DRUGSAFETYSITE.COM». Arxivat de l'original el 2013-12-05. [Consulta: 15 novembre 2011].

fda.gov (Global: 470^th place; Catalan: 690^th place)

Burkholz, Herbert «Giving Thalidomide a Second Chance». FDA Consumer. US Food and Drug Administration, 01-09-1997 [Consulta: 21 setembre 2006].
FDA, Center for Drug Evaluation and Research, July 16, 1998
FDA Approves Thalomid (thalidomide) to Treat Multiple Myeloma

fundaciongillow.org (Global: low place; Catalan: low place)

Castilla, E.E. [et al]. «Thalidomide, a current teratogen in South America». Teratology. Wiley-Liss, 54, 6, 1996, p. 273–7. Arxivat de l'original el 2012-03-24. DOI: 10.1002/(SICI)1096-9926(199612)54:6<273::AID-TERA1>3.0.CO;2-#. PMID: 9098920 [Consulta: 15 novembre 2011]. Arxivat 2012-03-24 a Wayback Machine.

gpo.gov (Global: 1,819^th place; Catalan: 1,838^th place)

permanent.access.gpo.gov

Bren, Linda «Frances Oldham Kelsey: FDA Medical Reviewer Leaves Her Mark on History». FDA Consumer. US Food and Drug Administration, 28-02-2001 [Consulta: 23 desembre 2009].

history.ca (Global: low place; Catalan: low place)

«Turning Points of History — Prescription for Disaster». History Television. Arxivat de l'original el 29 de setembre 2011. [Consulta: 24 febrer 2010].

ijdvl.com (Global: low place; Catalan: 9,335^th place)

Madnani NA, Khan KJ «Linear IgA bullous dermatosis of childhood: Response to thalidomide». Indian Journal of Dermatology, Venereology, and Leprology, 76, 4, 2010, p. 427. DOI: 10.4103/0378-6323.66601. PMID: 20657136.^{[Enllaç no actiu]}

imdb.com (Global: 22^nd place; Catalan: 23^rd place)

Nobody's Perfect Release Dates

koreamed.org (Global: low place; Catalan: low place)

synapse.koreamed.org

Ghassem, Solgi; Kariminia A., Abdi K, Darabi M, Ghareghozloo B. «Effects of combined therapy with thalidomide and glucantime on leishmaniasis induced by Leishmania major in BALB/c mice» (PDF). Korean Journal of Parasitology, 44, 1, març 2006, p. 55–61. Arxivat de l'original el 2012-05-03. DOI: 10.3347/kjp.2006.44.1.55. PMC: 2532651. PMID: 16514283 [Consulta: 15 novembre 2011]. Arxivat 2012-05-03 a Wayback Machine.

leicesterreviewofbooks.wordpress.com (Global: low place; Catalan: low place)

«(Interview) Kate Rigby, author of ‘Thalidomide Kid'». Leicester Review of Books, 19 novembre 2007 [Consulta: 29 setembre 2011]. «My latest book is about a boy called Daryl affected by the Thalidomide tragedy (he has no arms) and the way he copes with his disability through humor (he calls himself ‘Thalidomide Kid'). At the heart of the story is the burgeoning romance between Daryl and the deputy head's daughter, Celia, and the pains and prejudice they face in a 70s school setting.»

medic8.com (Global: low place; Catalan: low place)

«Thalidomide - medic8.com - Retrieved August 25, 2008». Arxivat de l'original el de desembre 20, 2009. [Consulta: de novembre 15, 2011].

nature.com (Global: 207^th place; Catalan: 136^th place)

Lebrin, Franck; Srun S., Raymond2 K, Martin S., van den Brink S, Freitas C., Bréant C., Mathivet T., Larrivée B., Thomas J., Arthur H., Westermann C., Disch F., Mager J., Snijder R., Eichmann A., Mummery C. «Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia». Nature Medicine, 16, 4, abril 2010, p. 420–8. DOI: 10.1038/nm.2131. PMID: 20364125.

nejm.org (Global: 2,717^th place; Catalan: 1,415^th place)

content.nejm.org

Singhal S, Mehta J, Desikan R, et al. «Antitumor activity of thalidomide in refractory multiple myeloma». The New England Journal of Medicine, 341, 21, November 1999, p. 1565–71. DOI: 10.1056/NEJM199911183412102. PMID: 10564685 [Consulta: 18 juny 2009].

nih.gov (Global: 5^th place; Catalan: 7^th place)

ncbi.nlm.nih.gov

Ito, T; Ando, H; Suzuki, T [et al]. «Identification of a primary target of thalidomide teratogenicity». Science, 327, 5971, març 2010, p. 1345–50. DOI: 10.1126/science.1177319. PMID: 20223979.
Silverman, William «The Schizophrenic Career of a "Monster Drug"». Pediatrics, 110, 2, 22-04-2002, p. 404–6. Arxivat de l'original el 2007-02-02. DOI: 10.1542/peds.110.2.404. PMID: 12165600 [Consulta: 15 novembre 2011].
Rao KV «Lenalidomide in the treatment of multiple myeloma». American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists, 64, 17, September 2007, p. 1799–807. DOI: 10.2146/ajhp070029. PMID: 17724360 [Consulta: 18 juny 2009].
Castilla, E.E. [et al]. «Thalidomide, a current teratogen in South America». Teratology. Wiley-Liss, 54, 6, 1996, p. 273–7. Arxivat de l'original el 2012-03-24. DOI: 10.1002/(SICI)1096-9926(199612)54:6<273::AID-TERA1>3.0.CO;2-#. PMID: 9098920 [Consulta: 15 novembre 2011]. Arxivat 2012-03-24 a Wayback Machine.
Madnani NA, Khan KJ «Linear IgA bullous dermatosis of childhood: Response to thalidomide». Indian Journal of Dermatology, Venereology, and Leprology, 76, 4, 2010, p. 427. DOI: 10.4103/0378-6323.66601. PMID: 20657136.^{[Enllaç no actiu]}
Brown, RD; Spencer A, Ho PJ, Kennedy N, Kabani K, Yang S, Sze DM, Aklilu E, Gibson J, Joshua DE «Prognostically significant cytotoxic T cell clones are stimulated after thalidomide therapy in patients with multiple myeloma». Leukemia & Lymphoma, 50, 11, 2009 Nov, p. 1860–4. DOI: 10.3109/10428190903216804. PMID: 19883313 [Consulta: 4 juny 2011].
Ghassem, Solgi; Kariminia A., Abdi K, Darabi M, Ghareghozloo B. «Effects of combined therapy with thalidomide and glucantime on leishmaniasis induced by Leishmania major in BALB/c mice» (PDF). Korean Journal of Parasitology, 44, 1, març 2006, p. 55–61. Arxivat de l'original el 2012-05-03. DOI: 10.3347/kjp.2006.44.1.55. PMC: 2532651. PMID: 16514283 [Consulta: 15 novembre 2011]. Arxivat 2012-05-03 a Wayback Machine.
Lebrin, Franck; Srun S., Raymond2 K, Martin S., van den Brink S, Freitas C., Bréant C., Mathivet T., Larrivée B., Thomas J., Arthur H., Westermann C., Disch F., Mager J., Snijder R., Eichmann A., Mummery C. «Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia». Nature Medicine, 16, 4, abril 2010, p. 420–8. DOI: 10.1038/nm.2131. PMID: 20364125.
Singhal S, Mehta J, Desikan R, et al. «Antitumor activity of thalidomide in refractory multiple myeloma». The New England Journal of Medicine, 341, 21, November 1999, p. 1565–71. DOI: 10.1056/NEJM199911183412102. PMID: 10564685 [Consulta: 18 juny 2009].
Gieseler F «Pathophysiological considerations to thrombophilia in the treatment of multiple myeloma with thalidomide and derivates». Thrombosis and Haemostasis, 99, 6, June 2008, p. 1001–7. DOI: 10.1160/TH08-01-0009. PMID: 18521500 [Consulta: 18 juny 2009].
Denz U, Haas PS, Wäsch R, Einsele H, Engelhardt M «State of the art therapy in multiple myeloma and future perspectives». European Journal of Cancer (Oxford, England : 1990), 42, 11, July 2006, p. 1591–600. DOI: 10.1016/j.ejca.2005.11.040. PMID: 16815703 [Consulta: 18 juny 2009].
Haas PS, Denz U, Ihorst G, Engelhardt M «Thalidomide in consecutive multiple myeloma patients: single-center analysis on practical aspects, efficacy, side effects and prognostic factors with lower thalidomide doses». Eur. J. Haematol., 80, 4, abril 2008, p. 303–9. DOI: 10.1111/j.1600-0609.2007.01022.x. PMID: 18182082.
Bennett CL, Angelotta C, Yarnold PR, et al. «Thalidomide- and lenalidomide-associated thromboembolism among patients with cancer». JAMA, 296, 21, December 2006, p. 2558–60. DOI: 10.1001/jama.296.21.2558-c. PMID: 17148721.
Teo SK, Colburn WA, Tracewell WG, Kook KA, Stirling DI, Jaworsky MS, Scheffler MA, Thomas SD, Laskin OL «Clinical pharmacokinetics of thalidomide». Clin Pharmacokinet., 43, 5, 2004, p. 311–327. DOI: 10.2165/00003088-200443050-00004. PMID: 15080764.
Stephens TD, Bunde CJ, Fillmore BJ «Mechanism of action in thalidomide teratogenesis». Biochemical Pharmacology, 59, 12, June 2000, p. 1489–99. DOI: 10.1016/S0006-2952(99)00388-3. PMID: 10799645.
Koch HP, Czejka MJ «Evidence for the intercalation of thalidomide into DNA: clue to the molecular mechanism of thalidomide teratogenicity?». Z. Naturforsch., C, J. Biosci., 41, 11–12, 1986, p. 1057–61. PMID: 2953123.
Huang PH, McBride WG «Interaction of [glutarimide-2-14C]-thalidomide with rat embryonic DNA in vivo». Teratogenesis, Carcinogenesis, and Mutagenesis, 17, 1, 1997, p. 1–5. DOI: 10.1002/(SICI)1520-6866(1997)17:1<1::AID-TCM2>3.0.CO;2-L. PMID: 9249925.
Therapontos C, Erskine L, Gardner ER, Figg WD, Vargesson N «Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation». Proceedings of the National Academy of Sciences of the United States of America, 106, 21, May 2009, p. 8573–8. DOI: 10.1073/pnas.0901505106. PMC: 2688998. PMID: 19433787 [Consulta: 18 juny 2009].
Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H «Identification of a primary target of thalidomide teratogenicity». Science, 327, 5971, 2010, p. 1345–1350. DOI: 10.1126/science.1177319. PMID: 20223979.
Anderson, KC «Lenalidomide and thalidomide: mechanisms of action--similarities and differences». Semin Hematol., Vol. 42, num. 4 Suppl 4, 2005, p. S3-8. DOI: http://dx.doi.org/10.1053/j.seminhematol.2005.10.001. PMID: 16344099.
Raghupathy R, Billett HH «Promising therapies in sickle cell disease». Cardiovasc Hematol Disord Drug Targets, 9, 1, març 2009, p. 1–8. Arxivat de l'original el 2013-05-11. DOI: 10.2174/187152909787581354. PMID: 19275572 [Consulta: 27 juny 2021]. Arxivat 2013-05-11 a Wayback Machine.

nytimes.com (Global: 7^th place; Catalan: 14^th place)

«The Public's Quiet Savior From Harmful Medicines». The New York Times, 13 setembre 2010.
Carl Zimmer «Answers Begin to Emerge on How Thalidomide Caused Defects». New York Times, 15 març 2010 [Consulta: 21 març 2010]. «As they report in the current issue of Science, a protein known as cereblon latched on tightly to the thalidomide.»
Dreifus «A Conversation with Rock Brynner — A 'Dark Remedy' Is Now Generating Light». The New York Times, 31-07-2001 [Consulta: 11 octubre 2010].

portlandphoenix.com (Global: low place; Catalan: low place)

Orpheus lives: A small good thing in Quastoff Retrieved on 2008-10-22

publicintegrity.org (Global: low place; Catalan: low place)

projects.publicintegrity.org

Ismail, MA. «FDA: A Shell of its Former Self». Pushing Prescriptions. The Centre for Public Integrity, 07-07-2005. Arxivat de l'original el 2011-10-12. [Consulta: 15 novembre 2011].

saude.df.gov.br (Global: low place; Catalan: low place)

Correio Braziliense «Talidomida volta a assustar». , 2006. Arxivat de l'original el 2012-03-13 [Consulta: 15 novembre 2011].

sciencedirect.com (Global: 137^th place; Catalan: 79^th place)

Paumgartten, J.R.; Chahoud, Ibrahim «Thalidomide embryopathy cases in Brazil after 1965». Reproductive Toxicology, 22, 1, 2006, p. 1-2. DOI: 10.1016/j.reprotox.2005.11.007.

sciencemag.org (Global: 1,019^th place; Catalan: 374^th place)

Ito, T; Ando, H; Suzuki, T [et al]. «Identification of a primary target of thalidomide teratogenicity». Science, 327, 5971, març 2010, p. 1345–50. DOI: 10.1126/science.1177319. PMID: 20223979.
Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H «Identification of a primary target of thalidomide teratogenicity». Science, 327, 5971, 2010, p. 1345–1350. DOI: 10.1126/science.1177319. PMID: 20223979.

seminhematol.org (Global: low place; Catalan: low place)

Anderson, KC «Lenalidomide and thalidomide: mechanisms of action--similarities and differences». Semin Hematol., Vol. 42, num. 4 Suppl 4, 2005, p. S3-8. DOI: http://dx.doi.org/10.1053/j.seminhematol.2005.10.001. PMID: 16344099.

spiritualityandpractice.com (Global: low place; Catalan: low place)

Movie Review of Nobody's Perfect

time.com (Global: 84^th place; Catalan: 120^th place)

«Medicine: The Thalidomide Disaster». Time, 10-08-1962 [Consulta: 15 abril 2011]. Arxivat 28 de setembre 2010 a Wayback Machine. «Còpia arxivada». Arxivat de l'original el 2010-09-28. [Consulta: 15 novembre 2011].

timesonline.co.uk (Global: 437^th place; Catalan: 381^st place)

Bowditch, Gillian «Can thalidomide ever be trusted?». The Sunday Times. News International Limited [Londres], 26 març 2006 [Consulta: 1r maig 2009].^{[Enllaç no actiu]}
Foggo, Daniel «Thalidomide 'was created by the Nazis'». The Times [Londres], 08-02-2009 [Consulta: 18 juny 2009]. Arxivat 2011-06-29 at Archive.is
Foggo, Daniel «Thalidomide victim Gary Syner to go on hunger strike». The Sunday Times. Times Newspapers Ltd. [Londres], 13 setembre 2009 [Consulta: 28 setembre 2009].^{[Enllaç no actiu]}
Flintoff, John-Paul «Thalidomide: the battle for compensation goes on». The Sunday Times. Times Newspapers Ltd. [Londres], 23 març 2008 [Consulta: 1r maig 2009]. Arxivat 2008-05-13 a Wayback Machine.

unsw.edu.au (Global: 4,700^th place; Catalan: 3,206^th place)

embryology.med.unsw.edu.au

Report of Thalidomide at University of New South Wales. See also main William McBride article.

web.archive.org (Global: 1^st place; Catalan: 1^st place)

«Thalidomide: Drug safety during pregnancy and breastfeeding / DRUGSAFETYSITE.COM». Arxivat de l'original el 2013-12-05. [Consulta: 15 novembre 2011].
Washington, Harriet A.. «Prudence and the Pill: Testing Thalidomide in the Global South», 14 gener 2011. Arxivat de l'original el 5 de novembre 2011. [Consulta: 15 novembre 2011].
Moghe, Vijay V; Ujjwala Kulkarni, Urvashi I Parmar «Thalidomide» (PDF). Bombay Hospital Journal. Bombay Hospital [Bombai], 50, 3, 2008, p. 446. Arxivat de l'original el 22 de juliol 2011 [Consulta: 25 octubre 2009]. Arxivat 22 de juliol 2011 a Wayback Machine.
«Medicine: The Thalidomide Disaster». Time, 10-08-1962 [Consulta: 15 abril 2011]. Arxivat 28 de setembre 2010 a Wayback Machine. «Còpia arxivada». Arxivat de l'original el 2010-09-28. [Consulta: 15 novembre 2011].
Mekdeci, Betty. «How a Commonly Used Drug Caused Birth Defects». Arxivat de l'original el 2013-12-18. [Consulta: 15 novembre 2011].
Flintoff, John-Paul «Thalidomide: the battle for compensation goes on». The Sunday Times. Times Newspapers Ltd. [Londres], 23 març 2008 [Consulta: 1r maig 2009]. Arxivat 2008-05-13 a Wayback Machine.
Mekdeci, Betty. «How a Commonly Used Drug Caused Birth Defects». Arxivat de l'original el 2013-12-18. [Consulta: 15 novembre 2011].
«Turning Points of History — Prescription for Disaster». History Television. Arxivat de l'original el 29 de setembre 2011. [Consulta: 24 febrer 2010].
«Thalidomide - medic8.com - Retrieved August 25, 2008». Arxivat de l'original el de desembre 20, 2009. [Consulta: de novembre 15, 2011].
Silverman, William «The Schizophrenic Career of a "Monster Drug"». Pediatrics, 110, 2, 22-04-2002, p. 404–6. Arxivat de l'original el 2007-02-02. DOI: 10.1542/peds.110.2.404. PMID: 12165600 [Consulta: 15 novembre 2011].
Anon. «Use of thalidomide in leprosy». WHO:leprosy elimination. WHO. Arxivat de l'original el 29 de setembre 2010. [Consulta: 22 abril 2010].
Ismail, MA. «FDA: A Shell of its Former Self». Pushing Prescriptions. The Centre for Public Integrity, 07-07-2005. Arxivat de l'original el 2011-10-12. [Consulta: 15 novembre 2011].
Castilla, E.E. [et al]. «Thalidomide, a current teratogen in South America». Teratology. Wiley-Liss, 54, 6, 1996, p. 273–7. Arxivat de l'original el 2012-03-24. DOI: 10.1002/(SICI)1096-9926(199612)54:6<273::AID-TERA1>3.0.CO;2-#. PMID: 9098920 [Consulta: 15 novembre 2011]. Arxivat 2012-03-24 a Wayback Machine.
Correio Braziliense «Talidomida volta a assustar». , 2006. Arxivat de l'original el 2012-03-13 [Consulta: 15 novembre 2011].
Ghassem, Solgi; Kariminia A., Abdi K, Darabi M, Ghareghozloo B. «Effects of combined therapy with thalidomide and glucantime on leishmaniasis induced by Leishmania major in BALB/c mice» (PDF). Korean Journal of Parasitology, 44, 1, març 2006, p. 55–61. Arxivat de l'original el 2012-05-03. DOI: 10.3347/kjp.2006.44.1.55. PMC: 2532651. PMID: 16514283 [Consulta: 15 novembre 2011]. Arxivat 2012-05-03 a Wayback Machine.
Raghupathy R, Billett HH «Promising therapies in sickle cell disease». Cardiovasc Hematol Disord Drug Targets, 9, 1, març 2009, p. 1–8. Arxivat de l'original el 2013-05-11. DOI: 10.2174/187152909787581354. PMID: 19275572 [Consulta: 27 juny 2021]. Arxivat 2013-05-11 a Wayback Machine.

who.int (Global: 213^th place; Catalan: 189^th place)

Anon. «Use of thalidomide in leprosy». WHO:leprosy elimination. WHO. Arxivat de l'original el 29 de setembre 2010. [Consulta: 22 abril 2010].

whonamedit.com (Global: 3,828^th place; Catalan: 2,144^th place)

Anon. «Widukind Lenz». who name it?. Ole Daniel Enersen. [Consulta: 1r maig 2009].

Talidomida (Catalan Wikipedia)

aappublications.org (Global: 6,006th place; Catalan: 3,218th place)

pediatrics.aappublications.org

acs.org (Global: 865th place; Catalan: 519th place)

pubs.acs.org

archive.org (Global: 6th place; Catalan: 15th place)

archive.today (Global: 28th place; Catalan: 10th place)

bbc.co.uk (Global: 11th place; Catalan: 21st place)

news.bbc.co.uk

bbc.co.uk

benthamdirect.org (Global: low place; Catalan: low place)

bhj.org (Global: low place; Catalan: low place)

biopoliticaltimes.org (Global: low place; Catalan: low place)

birthdefects.org (Global: low place; Catalan: low place)

bris.ac.uk (Global: 5,759th place; Catalan: 2,885th place)

chm.bris.ac.uk

cancerbackup.org.uk (Global: low place; Catalan: low place)

channel4.com (Global: 1,192nd place; Catalan: 1,558th place)

clinicaltrials.gov (Global: 4,259th place; Catalan: 3,031st place)

dailymail.co.uk (Global: 338th place; Catalan: 277th place)

doi.org (Global: 2nd place; Catalan: 4th place)

dx.doi.org

drugsafetysite.com (Global: low place; Catalan: low place)

fda.gov (Global: 470th place; Catalan: 690th place)

fundaciongillow.org (Global: low place; Catalan: low place)

gpo.gov (Global: 1,819th place; Catalan: 1,838th place)

permanent.access.gpo.gov

history.ca (Global: low place; Catalan: low place)

ijdvl.com (Global: low place; Catalan: 9,335th place)

imdb.com (Global: 22nd place; Catalan: 23rd place)

koreamed.org (Global: low place; Catalan: low place)

synapse.koreamed.org

leicesterreviewofbooks.wordpress.com (Global: low place; Catalan: low place)

medic8.com (Global: low place; Catalan: low place)

nature.com (Global: 207th place; Catalan: 136th place)

nejm.org (Global: 2,717th place; Catalan: 1,415th place)

content.nejm.org

nih.gov (Global: 5th place; Catalan: 7th place)

ncbi.nlm.nih.gov

nytimes.com (Global: 7th place; Catalan: 14th place)

portlandphoenix.com (Global: low place; Catalan: low place)

publicintegrity.org (Global: low place; Catalan: low place)

projects.publicintegrity.org

saude.df.gov.br (Global: low place; Catalan: low place)

sciencedirect.com (Global: 137th place; Catalan: 79th place)

sciencemag.org (Global: 1,019th place; Catalan: 374th place)

seminhematol.org (Global: low place; Catalan: low place)

spiritualityandpractice.com (Global: low place; Catalan: low place)

time.com (Global: 84th place; Catalan: 120th place)

timesonline.co.uk (Global: 437th place; Catalan: 381st place)

unsw.edu.au (Global: 4,700th place; Catalan: 3,206th place)

embryology.med.unsw.edu.au

web.archive.org (Global: 1st place; Catalan: 1st place)

who.int (Global: 213th place; Catalan: 189th place)

whonamedit.com (Global: 3,828th place; Catalan: 2,144th place)

aappublications.org (Global: 6,006^th place; Catalan: 3,218^th place)

acs.org (Global: 865^th place; Catalan: 519^th place)

archive.org (Global: 6^th place; Catalan: 15^th place)

archive.today (Global: 28^th place; Catalan: 10^th place)

bbc.co.uk (Global: 11^th place; Catalan: 21^st place)

bris.ac.uk (Global: 5,759^th place; Catalan: 2,885^th place)

channel4.com (Global: 1,192^nd place; Catalan: 1,558^th place)

clinicaltrials.gov (Global: 4,259^th place; Catalan: 3,031^st place)

dailymail.co.uk (Global: 338^th place; Catalan: 277^th place)

doi.org (Global: 2^nd place; Catalan: 4^th place)

fda.gov (Global: 470^th place; Catalan: 690^th place)

gpo.gov (Global: 1,819^th place; Catalan: 1,838^th place)

ijdvl.com (Global: low place; Catalan: 9,335^th place)

imdb.com (Global: 22^nd place; Catalan: 23^rd place)

nature.com (Global: 207^th place; Catalan: 136^th place)

nejm.org (Global: 2,717^th place; Catalan: 1,415^th place)

nih.gov (Global: 5^th place; Catalan: 7^th place)

nytimes.com (Global: 7^th place; Catalan: 14^th place)

sciencedirect.com (Global: 137^th place; Catalan: 79^th place)

sciencemag.org (Global: 1,019^th place; Catalan: 374^th place)

time.com (Global: 84^th place; Catalan: 120^th place)

timesonline.co.uk (Global: 437^th place; Catalan: 381^st place)

unsw.edu.au (Global: 4,700^th place; Catalan: 3,206^th place)

web.archive.org (Global: 1^st place; Catalan: 1^st place)

who.int (Global: 213^th place; Catalan: 189^th place)

whonamedit.com (Global: 3,828^th place; Catalan: 2,144^th place)